The interaction between cyclophilin A and CD147 has been reported to present a potential therapeutic target for the treatment of APE,22 while the signalling of ERK1/2 was also reported by previous studies to be associated with the pathogenesis of cardiac injury.11, 23. The gene discussed is PPIA; the disease is apparent mineralocorticoid excess.